The High Value Biorenewables Network (HVB) is one of six Phase II BBSRC Networks in Industrial Biotechnology and Bioenergy (BBSRC) funded for six years from January 2019. Details of all six Phase II NIBB are available at:
https://bbsrc.ukri.org/research/programmes-networks/research-networks/nibb/

High Value Biorenewables builds on the success of the High Value Chemicals from Plants Network, one of 13 Phase I BBSRC NIBB funded from January 2014 – December 2018. 

HVB Governance

The Network is managed by an Executive Group working with support from a Management Board. Together, these comprise the Network Leadership Team.

HVB Executive Group members

Professor Ian Graham Network Director	Centre for Novel Agricultural Products, University of York
Professor Anne Osbourn Network Co-Director	John Innes Centre
Dr Joe Ross Network Co-Director	University of York & Director of the Biorenewables Development Centre
Dr Caroline Calvert Associate Director	University of York
Dr Joyce Bennett Network Manager	University of York
Dr Gail Shuttleworth Network Manager	University of York
Stephanie Simpson Network Administrator	University of York

HVB Management Board members

Eleanor Binner	Associate Professor, University of Nottingham
Tim Bowser	Principal, Impact Science Consulting
Andrew Collis	Synthetic Biochemistry Technical Lead, GSK Pharma Supply Chain
Paul Fraser	Professor of Biochemistry, Royal Holloway University of London
Matthew Hodges	Director of Commercial Operations, Oxford Biotrans
Gary Loake	Group Leader, University of Edinburgh
Johnathan Napier	Flagship Leader, Rothamsted Research
Nicola Patron	Director, Earlham DNA Foundry, Earlham Institute
Simon Saxby (Chair)	Chief Executive Officer, Leaf Expression Systems Ltd
Monique Simmonds	Deputy Director of Science, Royal Botanic Gardens, Kew
Helen Townley	University Research Lecturer, University of Oxford
Rebecca Wood	Open Innovation Coordinator, Croda
Sanjay Nagarajan	Lecturer, University of Bath
Ronan Egan	Principal Scientist (Synthetic Biology) Endocryne Ltd